Sevelamer

Therapeutic Group

All Other Therapeutic Products, Anti-dotes

Indication Dosage

Hyperphosphataemia In Patients On Haemodialysis Or Peritoneal Dialysis Or Patients With Chronic Kidney Disease Not On Dialysis Who Have Aserum-phosphate Concentration Of 1.78 Mmol/litre Or More: 

  • Adult: Initially 2.4-4.8 G Daily In 3 Divided Doses To Be Taken With Meals And Adjusted According To Serum-phosphate Concentration Every 2-4 Weeks; Usual Dose 6 G Daily In 3 Divided Doses

Content

  • Tab 400mg /800mg: Sevelamer Hydrochloride 400mg /800mg.

Pregnancy

Use Only If Essential

Stability

  • Phosphate Binder

Contra Indications

  • Bowel Obstruction, Hypophosphataemia.

Precautions

  • Bowel Obstruction, Hypophosphataemia.

Lactation

  • Caution Advised

Side Effects

  • Gi Disturbance
  • Abdominal Pain
  • Constipation
  • Diarrhoea
  • Dyspepsia
  • Flatulence
  • Nausea
  • Vomiting.
  • Rare: Ileus
  • Intestinal Obstruction
  • Diverticulosis
  • Intestinal Perforation
  • Pruritus Rash